Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Pilot data indicates that pentazocine decreases manic symptoms in hospitalized individuals.
To follow up these initial findings, we plan to conduct a larger, more rigorous, double-blind
study. We will examine whether pentazocine, an agent with kappa-opiate activity, decreases
manic symptoms.